Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
Malik
S T
ST
Department of Medical Oncology, St. Bartholomew's and Homerton Hospital, London, England.
Rayner
H
H
Fletcher
J
J
Slevin
M L
ML
D000368:Aged; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000627:therapeutic use*
D008942:Mitoxantrone